"
Milnacipran for Attention-Deficit Hyperactivity Disorder Symptoms in Adult Asperger’s Disorder"
written by Hirobumi Mashiko, Hiromichi Ishikawa, Shuntaro Itagaki, Yasuko Takanashi, Norihiro Miyashita, Takaaki Okano, Shin-Ichi Niwa, Hirooki Yabe,
published by
Open Journal of Psychiatry,
Vol.4 No.3, 2014
has been cited by the following article(s):
|
[1]
|
Efficacy, safety, and tolerability of serotonin-norepinephrine reuptake inhibitors in controlling ADHD symptoms: a systematic review and meta-analysis
Middle East Current Psychiatry,
2024
DOI:10.1186/s43045-024-00400-1
|
|
|
|
|
[2]
|
Use of selective serotonin and norepinephrine reuptake inhibitors (SNRIs) in the treatment of autism spectrum disorder (ASD), comorbid psychiatric disorders and ASD-associated symptoms: a clinical review
CNS Spectrums,
2022
DOI:10.1017/S109285292000214X
|
|
|
|
|
[3]
|
Add-on Milnacipran Boosts Methylphenidate Response in an Adolescent With Attention-Deficit/Hyperactivity Disorder With Comorbid Anxiety and Enuresis
American Journal of Therapeutics,
2019
DOI:10.1097/MJT.0000000000000884
|
|
|
|
|
[4]
|
Add-on Milnacipran Boosts Methylphenidate Response in an Adolescent With Attention-Deficit/Hyperactivity Disorder With Comorbid Anxiety and Enuresis
American Journal of Therapeutics,
2019
DOI:10.1097/MJT.0000000000000884
|
|
|
|